{"organizations": [], "uuid": "ef41f613bed0ad5fc077934946ffed66b03bf14b", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/UKbankingFinancial/", "section_title": "Reuters: Financial Services and Real Estate", "url": "https://www.reuters.com/article/usa-healthcare-drugpricing/u-s-considering-expanding-medicare-drug-price-negotiation-idUSL2N1SL0K0", "country": "US", "domain_rank": 408, "title": "U.S. considering expanding Medicare drug price negotiation", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-05-14T16:59:00.000+03:00", "replies_count": 0, "uuid": "ef41f613bed0ad5fc077934946ffed66b03bf14b"}, "author": "", "url": "https://www.reuters.com/article/usa-healthcare-drugpricing/u-s-considering-expanding-medicare-drug-price-negotiation-idUSL2N1SL0K0", "ord_in_thread": 0, "title": "U.S. considering expanding Medicare drug price negotiation", "locations": [], "entities": {"persons": [{"name": "alex azar", "sentiment": "none"}, {"name": "azar", "sentiment": "none"}, {"name": "michael erman", "sentiment": "none"}, {"name": "trump", "sentiment": "none"}], "locations": [{"name": "u.s.", "sentiment": "none"}, {"name": "new york", "sentiment": "none"}], "organizations": [{"name": "medicare", "sentiment": "negative"}, {"name": "reuters staff", "sentiment": "none"}, {"name": "health and human services", "sentiment": "none"}, {"name": "medicare part d. azar", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "May 14, 2018 / 2:03 PM / Updated an hour ago U.S. considering expanding Medicare drug price negotiation Reuters Staff 1 Min Read\nNEW YORK, May 14 (Reuters) - The U.S. is considering expanding Medicare’s ability to negotiate the cost of drugs, Health and Human Services Secretary Alex Azar said in prepared remarks on Monday that followed up on President Trump’s speech on drug pricing last week.\nAzar said his agency will be considering an alternative system for buying Medicare Part B drugs, which would expand the negotiation of prescription drugs that are already covered under Medicare Part D.\nAzar also said that President Trump has called for merging Medicare Part B into Part D. (Reporting by Michael Erman)", "external_links": [], "published": "2018-05-14T16:59:00.000+03:00", "crawled": "2018-05-14T18:27:56.025+03:00", "highlightTitle": ""}